Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial

Similar Items

• An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses
  od: Pettersen, Frank O., i dr.
  Izdano: (2011)
• Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
  od: Lieske, Nora V., i dr.
  Izdano: (2015)
• Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.
  od: Christian Prebensen, i dr.
  Izdano: (2016-01-01)
• Regulation of Gag- and Env-Specific CD8(+) T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
  od: Prebensen, Christian, i dr.
  Izdano: (2016)
• Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
  od: Feruglio, Siri L., i dr.
  Izdano: (2013)